Effect on insulin production sorting and secretion by major histocompatibility complex class ii gene expression in the pancreatic β cell of transgenic mice

Gerold M. Grodsky, Yan Hui Ma, Betsey Cullen, Nora E Sarvetnick

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Expression of major histocompatibility complex (MHC) class II protein in islet p-cells of transgenic mice causes severe diabetes without an attendant autoimmune component. Little is known of the aberrant &cell function and site of biological lesions responsible for the diabetic state. Therefore, changes in (pro)insulin production, processing, sorting, storage, and secretion were evaluated using the in vitro perfused pancreas from male hyperglycemic BALB/cBYJ Tg (O pinsproAαd pinsproAβd) mice and a RIA capable of detecting mouse insulin or proinsulin with quantitative equivalency. Results were compared to control pancreases from normal BALB/cBYJ mice. Extractable pancreatic insulin plus proinsulin content in the transgenics was 4% of normal. Normal pancreases responded characteristically with a diphasic insulin release during 30.min stimulation by glucose, a response that was enhanced by subsequent forskolin. In contrast, hormone release from transgenic pancreases was undetectable; based on the sensitivity of the immunoassay, fractional secretion of the residual pancreatic hormone content from the transgenic pancreases was less than 25% of normal. Proinsulin or insulin constitutive release was also not detected in the absence or presence of glucose-containing stimuli even when experiments were extended to 3 h. In contrast, fractional secretion in response to nonglucose stimuli (carbachol-leucine and arginine-leucine) was greater than normal from the transgenic diabetic pancreases. Responses to glucose stimuli did not normalize even after 90 min in the absence of glucose. In other experiments, pancreases were stimulated with carbachol/leucine/forskolin for 90 min, and the proportion of proinsulin to insulin released by the regulated pathway was determined after Sep-Pak and HPLC separation of combined eluates. Proinsulin was undetectable (and, therefore, accounted for less than 10% of the total hormone secretion). It is concluded from the observations of hyperglycemia, low pancreatic insulin content, and impaired release that insulin production in the pancreas of the MHC diabetic transgenic is severely depressed. The limited insulin production and chronic hyperglycemia do not (as speculated) cause missorting to a constitutive pathway or impaired conversion of proinsulin to insulin, since a proportionately increased proinsulin release does not occur. Although the response of the secretory process to glucose-containing stimuli is almost completely destroyed, fractional secretion in response to nonglucose stimuli is enhanced. The possible contribution of hyperglycemia-induced P-cell desensitization or specific lesions in the glucose recognition signals induced by MHC expression are discussed. Results suggest that expression of MHC class II protein causes highly specific P-cell lesions which, in themselves, could be a contributing factor in human insulin-dependent diabetes.

Original languageEnglish (US)
Pages (from-to)933-938
Number of pages6
JournalEndocrinology
Volume131
Issue number2
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Major Histocompatibility Complex
Transgenic Mice
Proinsulin
Insulin
Gene Expression
Pancreas
Glucose
Leucine
Hyperglycemia
Carbachol
Colforsin
Pancreatic Hormones
Hormones
Secretory Pathway
Islets of Langerhans
Immunoassay
Arginine
Proteins
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Endocrinology

Cite this

Effect on insulin production sorting and secretion by major histocompatibility complex class ii gene expression in the pancreatic β cell of transgenic mice. / Grodsky, Gerold M.; Hui Ma, Yan; Cullen, Betsey; Sarvetnick, Nora E.

In: Endocrinology, Vol. 131, No. 2, 01.01.1992, p. 933-938.

Research output: Contribution to journalArticle

@article{8e60150402984527b741ae30dc63176b,
title = "Effect on insulin production sorting and secretion by major histocompatibility complex class ii gene expression in the pancreatic β cell of transgenic mice",
abstract = "Expression of major histocompatibility complex (MHC) class II protein in islet p-cells of transgenic mice causes severe diabetes without an attendant autoimmune component. Little is known of the aberrant &cell function and site of biological lesions responsible for the diabetic state. Therefore, changes in (pro)insulin production, processing, sorting, storage, and secretion were evaluated using the in vitro perfused pancreas from male hyperglycemic BALB/cBYJ Tg (O pinsproAαd pinsproAβd) mice and a RIA capable of detecting mouse insulin or proinsulin with quantitative equivalency. Results were compared to control pancreases from normal BALB/cBYJ mice. Extractable pancreatic insulin plus proinsulin content in the transgenics was 4{\%} of normal. Normal pancreases responded characteristically with a diphasic insulin release during 30.min stimulation by glucose, a response that was enhanced by subsequent forskolin. In contrast, hormone release from transgenic pancreases was undetectable; based on the sensitivity of the immunoassay, fractional secretion of the residual pancreatic hormone content from the transgenic pancreases was less than 25{\%} of normal. Proinsulin or insulin constitutive release was also not detected in the absence or presence of glucose-containing stimuli even when experiments were extended to 3 h. In contrast, fractional secretion in response to nonglucose stimuli (carbachol-leucine and arginine-leucine) was greater than normal from the transgenic diabetic pancreases. Responses to glucose stimuli did not normalize even after 90 min in the absence of glucose. In other experiments, pancreases were stimulated with carbachol/leucine/forskolin for 90 min, and the proportion of proinsulin to insulin released by the regulated pathway was determined after Sep-Pak and HPLC separation of combined eluates. Proinsulin was undetectable (and, therefore, accounted for less than 10{\%} of the total hormone secretion). It is concluded from the observations of hyperglycemia, low pancreatic insulin content, and impaired release that insulin production in the pancreas of the MHC diabetic transgenic is severely depressed. The limited insulin production and chronic hyperglycemia do not (as speculated) cause missorting to a constitutive pathway or impaired conversion of proinsulin to insulin, since a proportionately increased proinsulin release does not occur. Although the response of the secretory process to glucose-containing stimuli is almost completely destroyed, fractional secretion in response to nonglucose stimuli is enhanced. The possible contribution of hyperglycemia-induced P-cell desensitization or specific lesions in the glucose recognition signals induced by MHC expression are discussed. Results suggest that expression of MHC class II protein causes highly specific P-cell lesions which, in themselves, could be a contributing factor in human insulin-dependent diabetes.",
author = "Grodsky, {Gerold M.} and {Hui Ma}, Yan and Betsey Cullen and Sarvetnick, {Nora E}",
year = "1992",
month = "1",
day = "1",
doi = "10.1210/endo.131.2.1639031",
language = "English (US)",
volume = "131",
pages = "933--938",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Effect on insulin production sorting and secretion by major histocompatibility complex class ii gene expression in the pancreatic β cell of transgenic mice

AU - Grodsky, Gerold M.

AU - Hui Ma, Yan

AU - Cullen, Betsey

AU - Sarvetnick, Nora E

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Expression of major histocompatibility complex (MHC) class II protein in islet p-cells of transgenic mice causes severe diabetes without an attendant autoimmune component. Little is known of the aberrant &cell function and site of biological lesions responsible for the diabetic state. Therefore, changes in (pro)insulin production, processing, sorting, storage, and secretion were evaluated using the in vitro perfused pancreas from male hyperglycemic BALB/cBYJ Tg (O pinsproAαd pinsproAβd) mice and a RIA capable of detecting mouse insulin or proinsulin with quantitative equivalency. Results were compared to control pancreases from normal BALB/cBYJ mice. Extractable pancreatic insulin plus proinsulin content in the transgenics was 4% of normal. Normal pancreases responded characteristically with a diphasic insulin release during 30.min stimulation by glucose, a response that was enhanced by subsequent forskolin. In contrast, hormone release from transgenic pancreases was undetectable; based on the sensitivity of the immunoassay, fractional secretion of the residual pancreatic hormone content from the transgenic pancreases was less than 25% of normal. Proinsulin or insulin constitutive release was also not detected in the absence or presence of glucose-containing stimuli even when experiments were extended to 3 h. In contrast, fractional secretion in response to nonglucose stimuli (carbachol-leucine and arginine-leucine) was greater than normal from the transgenic diabetic pancreases. Responses to glucose stimuli did not normalize even after 90 min in the absence of glucose. In other experiments, pancreases were stimulated with carbachol/leucine/forskolin for 90 min, and the proportion of proinsulin to insulin released by the regulated pathway was determined after Sep-Pak and HPLC separation of combined eluates. Proinsulin was undetectable (and, therefore, accounted for less than 10% of the total hormone secretion). It is concluded from the observations of hyperglycemia, low pancreatic insulin content, and impaired release that insulin production in the pancreas of the MHC diabetic transgenic is severely depressed. The limited insulin production and chronic hyperglycemia do not (as speculated) cause missorting to a constitutive pathway or impaired conversion of proinsulin to insulin, since a proportionately increased proinsulin release does not occur. Although the response of the secretory process to glucose-containing stimuli is almost completely destroyed, fractional secretion in response to nonglucose stimuli is enhanced. The possible contribution of hyperglycemia-induced P-cell desensitization or specific lesions in the glucose recognition signals induced by MHC expression are discussed. Results suggest that expression of MHC class II protein causes highly specific P-cell lesions which, in themselves, could be a contributing factor in human insulin-dependent diabetes.

AB - Expression of major histocompatibility complex (MHC) class II protein in islet p-cells of transgenic mice causes severe diabetes without an attendant autoimmune component. Little is known of the aberrant &cell function and site of biological lesions responsible for the diabetic state. Therefore, changes in (pro)insulin production, processing, sorting, storage, and secretion were evaluated using the in vitro perfused pancreas from male hyperglycemic BALB/cBYJ Tg (O pinsproAαd pinsproAβd) mice and a RIA capable of detecting mouse insulin or proinsulin with quantitative equivalency. Results were compared to control pancreases from normal BALB/cBYJ mice. Extractable pancreatic insulin plus proinsulin content in the transgenics was 4% of normal. Normal pancreases responded characteristically with a diphasic insulin release during 30.min stimulation by glucose, a response that was enhanced by subsequent forskolin. In contrast, hormone release from transgenic pancreases was undetectable; based on the sensitivity of the immunoassay, fractional secretion of the residual pancreatic hormone content from the transgenic pancreases was less than 25% of normal. Proinsulin or insulin constitutive release was also not detected in the absence or presence of glucose-containing stimuli even when experiments were extended to 3 h. In contrast, fractional secretion in response to nonglucose stimuli (carbachol-leucine and arginine-leucine) was greater than normal from the transgenic diabetic pancreases. Responses to glucose stimuli did not normalize even after 90 min in the absence of glucose. In other experiments, pancreases were stimulated with carbachol/leucine/forskolin for 90 min, and the proportion of proinsulin to insulin released by the regulated pathway was determined after Sep-Pak and HPLC separation of combined eluates. Proinsulin was undetectable (and, therefore, accounted for less than 10% of the total hormone secretion). It is concluded from the observations of hyperglycemia, low pancreatic insulin content, and impaired release that insulin production in the pancreas of the MHC diabetic transgenic is severely depressed. The limited insulin production and chronic hyperglycemia do not (as speculated) cause missorting to a constitutive pathway or impaired conversion of proinsulin to insulin, since a proportionately increased proinsulin release does not occur. Although the response of the secretory process to glucose-containing stimuli is almost completely destroyed, fractional secretion in response to nonglucose stimuli is enhanced. The possible contribution of hyperglycemia-induced P-cell desensitization or specific lesions in the glucose recognition signals induced by MHC expression are discussed. Results suggest that expression of MHC class II protein causes highly specific P-cell lesions which, in themselves, could be a contributing factor in human insulin-dependent diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0026731392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026731392&partnerID=8YFLogxK

U2 - 10.1210/endo.131.2.1639031

DO - 10.1210/endo.131.2.1639031

M3 - Article

VL - 131

SP - 933

EP - 938

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -